Impact of Treatment of Dyslipidemia on Renal Function, Fat Deposits and Scarring in Patients with Persistent Nephrotic Syndrome

Publisher： Karger

E-ISSN： 2235-3186|91|4|612-619

ISSN： 1660-8151

Source： Nephron, Vol.91, Iss.4, 2002-07, pp. : 612-619

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of Admission Renal Function on the Treatment and Outcome of Patients with Acute Coronary Syndrome

By  

Cardiorenal Medicine, Vol. 7, Iss. 3, 2017-02 ,pp. : 169-178

Karger

Access to resources Recommend Favorite

Efficiency of 1-Year Treatment with Fluvastatin in Hyperlipidemic Patients with Nephrotic Syndrome

By  

American Journal of Nephrology, Vol. 19, Iss. 4, 1999-08 ,pp. : 492-494

Karger

Access to resources Recommend Favorite

Renal Function in Patients Treated with Cinacalcet for Persistent Hyperparathyroidism after Kidney Transplantation

By  

Kidney and Blood Pressure Research, Vol. 34, Iss. 2, 2011-01 ,pp. : 97-103

Karger

Access to resources Recommend Favorite

Hyporeninemic Hypoaldosteronism in Patients with Nephrotic Syndrome

By  

American Journal of Nephrology, Vol. 18, Iss. 3, 1998-05 ,pp. : 251-255

Karger

Access to resources Recommend Favorite

Nephrotic Syndrome with Portal, Splenic and Renal Vein Thrombosis

By  

Nephron, Vol. 92, Iss. 3, 2002-09 ,pp. : 680-684

Karger

Access to resources Recommend Favorite